Clinical Trial: Alirocumab in Patients with Sepsis
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Sepsis
Study Type: INTERVENTIONAL
Official Title: PCSK9 and Lipid Metabolism in Sepsis (PALMS) : a Two-center, Phase 1b Randomized, Placebo-controlled, Double-blind, Clinical Trial of Alirocumab in Patients with Sepsis
Brief Summary:
The purpose of this study is to determine whether the drug alirocumab, which may lower cholesterol, can reduce the amount of inflammation caused by an infection that has caused either low blood pressure or difficulty breathing.Participants will be randomized to receive a single IV infusion of alirocumab or a placebo.
Read more